Lyme Disease: A Role for Coenzyme Q10 Supplementation?

doi:10.3390/antiox11040667

Paper

Lyme Disease: A Role for Coenzyme Q10 Supplementation?

Published Mar 30, 2022 · D. Mantle, Nadia Turton, I. Hargreaves

Antioxidants

1

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Lyme disease results from a bacterial infection following a bite from an infected tick. Patients are initially treated with antibiotics; however, in cases where antibiotic treatment is delayed, or when patients do not respond to antibiotic treatment, fatigue may develop alongside problems affecting the nervous system, cardiovascular system, and joints. It is thought that most of the damage to these tissues results from the excessive inflammatory response of the host, involving a self-reinforcing cycle of mitochondrial dysfunction, oxidative stress and inflammation. In this article, we review the potential role of supplementary coenzyme Q10 (CoQ10) in mediating the pathogenic mechanism underlying Lyme disease, on the basis of its role in mitochondrial function, as well as its anti-inflammatory and antioxidant actions.

Rigorous Journal

Study Snapshot

Coenzyme Q10 supplementation may play a role in mediating the pathogenic mechanism underlying Lyme disease, due to its role in mitochondrial function, anti-inflammatory, and antioxidant actions.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Lyme Disease: A Role for Coenzyme Q10 Supplementation?

References

Citations